SEARCH

SEARCH BY CITATION

References

  • Allen, T. J. (1977). Managing the Flow of Technology: Technology Transfer and the Dissemination of Technological Information with the R&D Organization. MIT Press, Cambridge, MA.
  • Allen, T. J., D. Lee and M. Tushman (1980). ‘R&D performance as a function of internal communication, project management and the nature of work’, IEEE Transactions on Engineering Management, EM-27, (1), pp. 212.
  • Amit, R. and P. Schoemaker (1993). ‘Strategic assets and organizational rent’, Strategic Management Journal, 14(1), pp. 3346.
  • Barney, J. (1986). ‘Strategy factor market: Expectation, luck and business strategy’, Management Science, 32(10), pp. 12311241.
  • Barney, J. (1991). ‘Firm resources and sustained competitive advantage’, Journal of Management, 17, (1), pp. 99120.
  • Burgelman, R. (1994). ‘Fading memories: A process study of strategic business exit in dynamic environments’, Administrative Science Quarterly, 39(1), pp. 2456.
  • Christensen, C. (1992). ‘Exploring the limits of the technology S-curve, Parts I and II’, Production and Operations Management, 1(4), pp. 334366.
  • Clark, K. and T. Fujimoto (1991). Product Development in the World Automobile Industry. Harvard Business School Press, Boston, MA.
  • Cockburn, I. and Z. Griliches (1988). ‘Industry effects and appropriability measures in the stock market's valuation of R&D and patents’, American Economic Review Papers and Proceedings, 78(2), pp. 419423.
  • Cockburn, I. and R. Henderson (1994). ‘Racing to invest? The dynamics of competition in ethical drug discovery’, Journal of Economics and Management Strategy, 3(3), pp. 481519.
  • Cool, K. and D. Schendel (1988). ‘Performance differences among strategic group members’, Strategic Management Journal, 9(3), pp. 207223.
  • Decision Resources, Inc. (December 1990). Worldwide Pharmaceutical Industry, Report 901201. Decision Resources, Inc., Burlington, MA.
  • Dierickx, I. and K. Cool (1989). ‘Asset stock accumulation and sustainability of competitive advantage’, Management Science, 35(12), pp. 15041513.
  • Dosi, G. and D. J. Teece (1993). ‘Organizational competencies and the boundaries of the firm’, University of California at Berkeley, Consortium on Competitiveness and Cooperation, Working Paper 93–11.
  • Gambardella, A. (1992). ‘Competitive advantage from in-house scientific research: The U.S. pharmaceutical industry in the 1980s’, Research Policy, pp. 117.
  • Gourieroux, C., A. Monfort and A. Trognon (1984). ‘Pseudo-maximum likelihood methods: Applications to Poisson models’, Econometrica, 52(3), pp. 701720.
  • Grabowski, H. G. and J. M. Vernon (1990). ‘A new look at the returns and risks to pharmaceutical R&D’, Management Science, 36(7), pp. 804821.
  • Greenan, N., D. Guellec, G. Broussaudier and L. Miotti (1993). ‘Firm organization, technology and performance: An empirical study’, working paper, INSEF Department of Economic Studies, France.
  • Hall, B. H. (1990). ‘The manufacturing sector master file: 1959–1987’, National Bureau of Economic Research working paper #3366, Cambridge, MA.
  • Hansen, G. S. and B. Wernerfelt (1989). ‘Determinants of firm performance: The relative importance of economic and organizational factors’, Strategic Management Journal, 10(5), pp. 399411.
  • Hauser, J. and D. Clausing (May–June 1988). ‘The house of quality’, Harvard Business Review, pp. 6373.
  • Hausman, J., B. H. Hall and Z. Griliches (1984). ‘Econometric models for count data with an application to the patents-R&D relationship’, Econometrica, 52(4), pp. 909938.
  • Henderson, R. (1993). ‘Underinvestment and incompetence as responses to radical innovation: Evidence from the semiconductor photolithographic alignment equipment industry’, Rand Journal of Economics, 24(2), pp. 248270.
  • Henderson, R. (1994). ‘The evolution of integrative capability: Innovation in cardiovascular drug discovery’, Industrial and Corporate Change, 3(3), forthcoming.
  • Henderson, R. M. and K. B. Clark (1990). ‘Architectural innovation: The reconfiguration of existing product technologies and the failure of established firms’, Administrative Science Quarterly, 35, pp. 930.
  • Henderson, R. and I. Cockburn (1994). ‘Scale, scope and spillovers: The determinants of research productivity in drug discovery’, NBER working paper no. 4466, revised.
  • Hirsch, P. (September 1975). ‘Organizational effectiveness and the institutional environment’, Administrative Science Quarterly, 20, pp. 327343.
  • Hitt, M. A. and R. D. Ireland (1985). ‘Corporate distinctive competence, strategy, industry and performance’, Strategic Management Journal, 6(3), pp. 273293.
  • Holmstrom, B. (1989) ‘Agency costs and innovation’, Journal of Economic Behavior and Organization, 12(3), pp. 305327.
  • Iansiti, M. (1993) ‘Science-based product development: An empirical study of the mainframe computer industry’, Harvard Business School working paper 92–083, revised.
  • Ichniowski, C., K. Shaw and G. Prennushi (August 1993). ‘The effects of human resource management on productivity’, Mimeo, Columbia University.
  • Itami, H. with T. Roehl (1987). Mobilizing Invisible Assets. Harvard University Press, Cambridge, MA.
  • Jaffe, A. (1986) ‘Technological opportunity and spillovers of R&D: Evidence from firms' patents, profits and market value’, American Economic Review, 76, pp. 9841001.
  • Katz, R. (ed.) (1988). Managing Professionals in Innovative Organizations: A Collection of Readings. Harper Business, New York.
  • Koenig, M. (1983). ‘A bibliometric analysis of pharmaceutical research’, Research Policy, 12, pp. 1536.
  • Kogut, B. and D. Kim (May 1991). ‘Technological accumulation, growth options, and the sequence of entry’, Mimeo, Wharton School. Presented at the Wharton Conference on the Evolution of Firm Capabilities.
  • Kogut, B. and U. Zander (1992). ‘Knowledge of the firm, combinative capabilities, and the replication of technology’, Organization Science, 3(3), pp. 383397.
  • Lawrence, P. R. and J. W. Lorsch (1967). Organization and Environment: Managing Differentiation and Integration. Irwin, Homewood, IL.
  • Leonard-Barton, D. (1992). ‘Core capabilities and core rigidities: A paradox in managing new product development’, Strategic Management Journal, Summer Special Issue, 13, pp. 111126.
  • Lippman, S. A. and R. P. Rumelt (1982). ‘Uncertain imitability: An analysis of interfirm difference in efficiency under competition’, Bell Journal of Economics, 13(2), pp. 418438.
  • Milgrom, P. and J. Roberts (1990). ‘The economics of modern manufacturing: Technology, strategy and organization’, American Economic Review, pp. 511528.
  • Minsker, D. H., J. S. MacDonald, R. T. Robertson and D. L. Bokelman (1983). ‘Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase’, Teratology, 28(30), pp. 449456.
  • Mitchell, W. (1989). ‘Whether and when? Probability and timing of incumbent's entry into emerging industrial subfields’, Administrative Science Quarterly, 34, pp. 208230.
  • Mitchell, W. (1992). ‘Are more good things better: Or will technical and market capabilities conflict when a firm expands?’, Industrial and Corporate Change, 1(2), pp. 327346.
  • Montgomery, C. A. and B. Wernerfelt (1988). ‘Diversification, Ricardian rents, and Tobin's q’, Rand Journal of Economics, 19, pp. 623632.
  • Nelson, R. (1991). 'Why do firms differ and how does it matter?, Strategic Management Journal, Winter Special Issue, 12, pp. 6174.
  • Penrose, E. T. (1959). The Theory of the Growth of the Firm. Wiley, New York.
  • Peteraf, M. (1993). ‘The cornerstones of competitive advantage: A resource-based view’, Strategic Management Journal, 14(3), pp. 179191.
  • Porter, M. (1980). Competitive Strategy. Free Press, New York.
  • Roberts, E. and O. Hauptman (1986). ‘The process of technology transfer to the new biomedical and pharmaceutical firm’, Research Policy, 15, pp. 107119.
  • Rumelt, R. P. (1991). ‘How much does industry matter?’, Strategic Management Journal, 12(3), pp. 167185.
  • Sapienza, A. (1994). ‘Measuring organizational knowledge’, Mimeo, Graduate School for Health Studies, Simmons College, Boston, MA.
  • Selznick, P. (1957). Leadership in Administration: A Sociological Interpretation. Harper & Row, New York.
  • Sheck, L., C. Cox, H. Davis, G. Trimble, W. Wardell and R. Hansen (1984). ‘Success rates in the U.S. drug development system’, Clinical Pharmacology and Therapeutics, 36(5), pp. 574583.
  • Spender, J-C. (1994). ‘The geographics of strategic competence’, Mimeo, Rutgers University. Presented at the Prince Bertil Symposium on the Dynamic Firm, Stockholm.
  • Tabrizi, B. and K. Eisenhardt (1994). ‘Accelerating product development’, Mimeo, Stanford University, Department of Industrial Engineering.
  • Teece, D. J., G. Pisano and A. Shuen (1992). ‘Dynamic capabilities and strategic management’, Mimeo, Haas School of Business, University of California, Berkeley, CA.
  • Von Hippel, E. (1988). The Sources of Innovation. Oxford University Press, Oxford.
  • Wernerfelt, B. (1984). ‘A resource-based view of the firm’, Strategic Management Journal, 5(2), pp. 171180.
  • Westney, E. (1991). ‘Country patterns in R&D organization: The United States and Japan’. In B.Kogut (ed.), Country Competitiveness and the Organization of Work. Oxford University Press, New York, pp. 3654.